• Is Precision Medicine Ready For Data From Billions Of Cells?

    Bio-IT World | Popular opinion is that two big shifts have changed the game for bioinformatics. The first is single cell ‘omics, the other is a more recent move to a new model of drug discovery that looks to leverage the vast amounts of human genetic data now being generated in support of precision medicine. But to achieve datasets with the 100,000s of patients and treatment conditions that are needed for statistical power in pharma R&D and precision medicine, IT tools to manage billions of cells are essential.

    Feb 3, 2021

  • Intel, Google Donate Compute Credits, Cloud Space To All Of Us Program

    Bio-IT World | Intel and Google have joined the National Institutes of Health (NIH) All of Us Research Program in its historic effort to improve population health by making biomedical data from underrepresented groups available to COVID-19 researchers nationwide via the Researcher Workbench.

    Feb 2, 2021

  • H3Africa Consortium Primes A Continent For Large-Scale Genomics Research

    Bio-IT World | Only a fraction of the genetic diversity among African individuals had previously been surveyed—even by large-scale efforts such as the 1000 Genomes Project. That’s why H3Africa’s sequencing is so important. A study published last year in Nature found evidence for natural selection in and around 62 previously unreported genes.

    Feb 2, 2021

  • Bio-IT World Opens 2021 Innovative Practices Awards Program

    Bio-IT World | Bio-IT World is accepting entries for the 2021 Innovative Practices Awards competition. The deadline for entry is March 19, 2021, and the $300 application fee will be waived for entrants who meet the early deadline of February 19, 2021.

    Jan 29, 2021

  • Profile of T Cells, Broadly Neutralizing Antibodies, Anti-Viral Targets: COVID-19 Updates

    Bio-IT World I Severe infection associated with myeloid immune cells, potential Achilles heel of coronaviruses identified, melatonin synthesized in lungs could have protective effect. Plus: NSAID use during COVID-19 is time-dependent on its harm or benefit and NAU to test Allarity drug against Coronavirus Variant B117.

    Jan 29, 2021

  • VAST Data’s New Architecture With NVIDIA, Mount Sinai’s New Center For Psychedelic Psychotherapy, More

    Bio-IT World | New products for high-content imaging, virus reagents and enrichment, software for small molecule design, and pharmacokinetic simulation. Plus: acquisitions in drug discovery services and partnerships for data analysis, single cell analysis, machine learning, and more.

    Jan 28, 2021